Senior professionals and middle managers are experiencing increased burnout and stress, leading to higher alcohol consumption, and there is a need for better support and resources for mental health and addiction treatment in Australia, according to Ruth Limkin, Founder of The Banyans and Chief Development Officer at parent Sana Health Group.
“Burnout and stress is likely due to the immense pressure and crisis management they have been facing, leading to a need for self-care. Middle managers are more likely to take out work stress on their family, so it’s important to have conversations and provide support.”, says Ms Limkin.
Alcohol consumption has increased significantly during COVID, with one in three senior managers and 50% of middle managers and the wider workforce drinking more when stressed, including day drinking while working from home.
Australian Health Journal spoke with Ms Limkin, on the Sana Health treatment centres in Sunshine Coast, Brisbane and Byron Bay having different client types, with some people self-medicating undiagnosed mental health conditions, and it can be confusing for them to find help.
Sana Health Group offers a wide range of practitioners and treatment programs for mental health, addiction, and eating disorders in Australia. However Ms Limkin raises the issue that in primary health GPs need more funding and support for better patient care and understanding of available options.
“The environment where you receive care affects the care you receive, and it’s important to help patients navigate the healthcare system and understand their treatment options.”, says Ms Limkin.
According to Ms Limkin, healthcare professionals need more resources and time to collaborate with patients and provide holistic care for better results in the Australian health system.
Practitioners need time to work collaboratively with patients using evidence-based research and at Sana Healthcare centres, a more holistic approach to wellbeing is taken to deliver better results.
-
Bionic eye trial shows improvements in functional vision for retinitis pigmentosa
Results of the first clinical trial of Australia’s ‘second generation’ bionic eye have demonstrated ‘substantial improvement’ in four participants’ functional vision, daily activities and quality of life over a period of more than two and a half years.
Led by the Centre for Eye Research Australia, Bionics Institute, University of Melbourne and Royal Victorian Eye and Ear Hospital, the trial findings add to interim results which showed that the second-generation bionic eye developed by Australian company Bionic Vision Technologies provided rapid improvements for four patients with blindness caused the genetic eye condition retinitis pigmentosa.
-
Investments to address health inequities in Prostate Cancer Care
Income, education, geographical location, and discrimination based on ethnicity, race, gender and sexual orientation, are only a fraction of factors that can negatively affect a person’s quality of cancer care. This is defined as the “equity gap” and it’s costing people their lives.
Timed to coincide with World Cancer Day 4th February 2025, Movember announced prostate cancer investment of $5.5 million. Eighteen grants (16 proposals and 2 community development grants) are slated to directly tackle inequities in prostate cancer care. The funding will be over three years with the grants spread across five countries – six in Canada, five in the United Kingdom, three in Australia, three in the United States and one in Ireland – each having a specific focus population and care area.
-
HEALTH CARE BRIEF: Pelvic Floor Dysfunction
Pelvic Floor Dysfunction – Lived experience, symptoms, diagnosis and treatment options
